Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “treatment”

2,520 pharma patents match "treatment" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,520
Index total 30,257
Page 24 / 105

Quick answer

This filtered view shows 2,520 pharmaceutical patents matching "treatment" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,520 results for “treatment” · 30,257 patents in full index Clear search

  1. US 11479530

    Synthetic sphingolipid-like molecules, drugs, methods of their synthesis and methods of treatment

    The Regents of the University of California · Granted Oct 25, 2022 · Expires Oct 20, 2042

    granted

  2. US 11479771

    Antisense oligonucleotides for the treatment of eye disease

    ProQR Therapeutics II B.V. · Granted Oct 25, 2022 · Expires Oct 20, 2042

    granted

  3. US 11472870

    Pharmaceutical composition for safe and effective treatment of knee and/or hip pain

    REGENERON PHARMACEUTICALS, INC. · Granted Oct 18, 2022 · Expires Oct 13, 2042

    granted

  4. US 11472888

    Reelin antibodies for treatment of atherosclerosis

    The Board of Regents of the University of Texas System · Granted Oct 18, 2022 · Expires Oct 13, 2042

    granted

  5. US 11464784

    Inhibition of aminocylase 3 (AA3) in the treatment of cancer

    The Regents of the University of California · Granted Oct 11, 2022 · Expires Oct 6, 2042

    granted

  6. US 11464830

    Treatment of inflammatory conditions by delivery of interleukin-1 receptor antagonist fusion protein

    REGENERON PHARMACEUTICALS, INC. · Granted Oct 11, 2022 · Expires Oct 6, 2042

    granted

  7. US 11464841

    TERT immunogenic compositions and methods of treatment using the same

    Inovio Pharmaceuticals, Inc. · Granted Oct 11, 2022 · Expires Oct 6, 2042

    granted

  8. US 11464755

    Antiviral treatments

    BioCryst Pharmaceuticals, Inc. · Granted Oct 11, 2022 · Expires Oct 6, 2042

    granted

  9. US 11464768

    Pimavanserin alone or in combination for use in the treatment of Alzheimer's disease psychosis

    ACADIA Pharmaceuticals Inc. · Granted Oct 11, 2022 · Expires Oct 6, 2042

    granted

  10. US 11459587

    Materials and methods for treatment of pain related disorders

    Vertex Pharmaceuticals Incorporated · Granted Oct 4, 2022 · Expires Sep 29, 2042

    granted

  11. US 11458154

    Treatment of CYR61- and VEGF-mediated conditions

    VANDA PHARMACEUTICALS INC. · Granted Oct 4, 2022 · Expires Sep 29, 2042

    granted

  12. US 11458143

    Method of treatment of attention deficit/hyperactivity disorder (ADHD)

    Supernus Pharmaceuticals, Inc. · Granted Oct 4, 2022 · Expires Sep 29, 2042

    granted

  13. US 11459320

    Deuterated Alpha5 subunit-selective negative allosteric modulators of gamma-aminobutyric acid type A receptors as fast acting treatment for depression and mood disorders

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 4, 2022 · Expires Sep 29, 2042

    granted

  14. AU 2021230529

    Use of compounds in the treatment of fungal infections

    BASILEA PHARMACEUTICA INTERNATIONAL AG ALLSCHWIL [CH] · Granted Sep 29, 2022 · Expires Sep 24, 2042

    granted

  15. US 11453655

    Modulator of the cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator

    Vertex Pharmaceuticals Incorporated · Granted Sep 27, 2022 · Expires Sep 22, 2042

    granted

  16. US 11447797

    AAV with unique capsid protein VP1 and methods of using for treatment

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 20, 2022 · Expires Sep 15, 2042

    granted

  17. US 11446323

    Compositions and methods for the treatment of fibrotic diseases

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Sep 20, 2022 · Expires Sep 15, 2042

    granted

  18. US 11446353

    Compositions and methods for the treatment of fungal infections

    Arizona Board of Regents on Behalf of Northern Arizona University · Granted Sep 20, 2022 · Expires Sep 15, 2042

    granted

  19. US 11439669

    C. novyi for the treatment of solid tumors in humans

    Biomed Valley Discoveries, Inc. · Granted Sep 13, 2022 · Expires Sep 8, 2042

    granted

  20. US 11439615

    Lipoxin and lipoxin analogue mediated neuroprotection and treatments

    The Regents of the University of California · Granted Sep 13, 2022 · Expires Sep 8, 2042

    granted

  21. US 11439641

    Pyrimidine JAK inhibitors for the treatment of skin diseases

    Theravance Biopharma R&D IP, LLC · Granted Sep 13, 2022 · Expires Sep 8, 2042

    granted

  22. US 11439695

    Kidney injury treatment

    The Regents of the University of California · Granted Sep 13, 2022 · Expires Sep 8, 2042

    granted

  23. US 11434502

    Treatment of amyotrophic lateral sclerosis (ALS)

    VOYAGER THERAPEUTICS, INC. · Granted Sep 6, 2022 · Expires Sep 1, 2042

    granted

  24. US 11433088

    Methods for treatment of vascular endothelial dysfunction using nicotinamide mononucleotide

    The Regents of the University of Colorado, a Body Corporate · Granted Sep 6, 2022 · Expires Sep 1, 2042

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.